Related Experiment Video
Updated: Aug 17, 2025
09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
8.9K
Silent Hypoxemia in COVID-19 Pneumonia
Akinori Ebihara1, Asako Kitahara2, Tokuzen Iwamoto2
1Department of Pulmonary Medicine, Tokai University, Tokyo Hospital, Tokyo, Japan. akinoriebihara@tok.u-tokai.ac.jp.
Advances in Experimental Medicine and Biology
|December 17, 2022
Summary
Silent hypoxemia in COVID-19 patients means low oxygen levels without noticeable shortness of breath. This study explores mechanisms behind this phenomenon in severe cases.
Area of Science:
- Respiratory Medicine
- Infectious Diseases
- Neurology
Background:
- Coronavirus Disease 2019 (COVID-19) can cause hypoxemia, a dangerous drop in blood oxygen.
- Patients may experience severe hypoxemia without the typical symptom of dyspnea (shortness of breath), termed silent hypoxemia.
- This disconnect between hypoxemia and dyspnea complicates early detection and treatment.
Purpose of the Study:
- To investigate the underlying mechanisms of silent hypoxemia in COVID-19 patients.
- To analyze clinical cases to understand how the respiratory control system is affected.
- To identify potential disruptions in the neural pathways transmitting respiratory sensation.
Main Methods:
- Retrospective analysis of three severe COVID-19 pneumonia cases admitted to a dedicated treatment hospital.
- Inclusion criteria: patients aged 58-86 with hypoxemia and tachypnea.
- Examination of clinical data focusing on respiratory rate, oxygen saturation, and subjective symptoms.
Main Results:
- Observed significant tachypnea (rapid breathing) and hyperventilation in patients with hypoxemia.
- Hypoxemia did not correlate with the perceived severity of dyspnea.
- Evidence suggests information transmission from carotid bodies to respiratory muscles occurred, but sensory feedback to the cerebral cortex was impaired.
Conclusions:
- COVID-19 may specifically affect the respiratory control system, leading to silent hypoxemia.
- Impaired transmission of respiratory sensory information to the brain's sensory area is implicated.
- Further research is needed to pinpoint the exact neurological pathways involved in this phenomenon.
More Related Videos
Related Concept Videos
01:21Acute Respiratory Failure-II
314
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
01:23Acute Respiratory Failure-IV
189
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
189
01:23Hypoxia
1.2K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.2K
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
303
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
303
01:25Hyperpnea and Hyperventilation
1.2K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K